Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: GROUP N(0.75% hyperbaric ropivacaine and nalbuphine): 0.75% hyperbaric ropivacaine 2.2 ml (16.5 mg)+0.8 ml (0.8mg) of nalbuphine (N) intrathecally once.
Post operative analgesic efficac
Sponsors
DR MRIDULA T V
Eligibility
Inclusion criteria
Inclusion criteria: 1. ASA physical status 1 and 2 2. BMI range of 18.5 to 24.9
Exclusion criteria
Exclusion criteria: 1.Infection at the site 2.Spinal deformity such as kyphoscoliosis 3.Bleeding disorders 4.Allergic reaction to study drugs 5.Patients on tranquilizers,hypnotics,sedatives and other psychotropic drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative analgesic durationTimepoint: Pain assessment 2 hourlies until 12 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of motor blockadeTimepoint: Assessed 2 hourlies until 12 hours of post surgery;Duration of sensory blockadeTimepoint: Assessed 2 hourlies until 12 hours of post surgery;The onset of sensory and motor blockade Timepoint: Assessed immediately after spinal injection then, every 3 minutes until 15 minutes, then every 10 minutes upto 1 hour, then every 30 minutes upto 2 hours and then hourly till the end of the surgery | — |
Countries
India
Contacts
Public ContactDR Jyothi B
Karnataka Institute of Medical Sciences
Outcome results
None listed